Skip to main content

Day: March 13, 2026

Novonesis issues EUR 1.7 billion senior unsecured notes

On March 12, 2026, Novonesis, through Novozymes A/S, successfully priced and closed an aggregate principal amount of EUR 1.7 billion senior unsecured notes (the “Notes”). The issuance was completed under the newly established EUR 4 billion Euro Medium Term Note (EMTN) Programme, dated March 10, 2026. The Notes will be issued on March 19, 2026, and listed on the Luxembourg Stock Exchange. This inaugural issuance consists of three tranches with maturities ranging from 4 to 11 years and fixed interest rates ranging from 3.25% to 4.00%. Novonesis has been rated A- (stable outlook) by Standard & Poor’s (S&P). The net proceeds from the transaction will be used to refinance existing debt and for general corporate purposes. For further details about the EMTN Programme and this issuance, please visit our website.Contact...

Continue reading

Copenhagen Airports A/S Annual Report 2025

Today, Copenhagen Airports A/S issues the Group Annual Report for the financial year 2025. The report is now available and attached to this announcement. The Group Annual Report shows a pre-tax profit of DKK 1,625 million for 2025. COPENHAGEN AIRPORTS A/SP.O. Box 74Lufthavnsboulevarden 6DK-2770 Kastrup Contact:Rasmus LundCFO Telephone: +45 32312800E-mail: cphpresse@cph.dkwww.cph.dkCVR no. 14 70 72 04AttachmentsCopenhagen Airports AS Group Annual Report 2025CPH-2025-12-31-enAnnouncement Copenhagen Airports AS Annual Report 2025

Continue reading

CMS(867.HK/8A8.SG):Ruxolitinib Phosphate Cream (Lumirix®) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo

SHENZHEN, CHINA, March 13, 2026 (GLOBE NEWSWIRE) — On 12 March 2026, China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health, which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited) has its innovative prescription medicine ruxolitinib phosphate cream (Lumirix®) (the “Product”, marketed as Opzelura® in the U.S., Europe and Canada) recorded the initial prescriptions for vitiligo patients across 30 provincial-level regions. The prescriptions cover approximately a thousand influential public and private medical institutions in the field of skin health and disease management, including Huashan Hospital, Fudan University, Shanghai Skin Disease...

Continue reading

German State Minister for Economic Affairs Visits Cabka Recycling Company in Weira

Amsterdam, 13 March 2026. Cabka N.V. (together with its subsidiaries “Cabka”, or the “Company”), specialized in transforming hard to recycle plastic waste into innovative Reusable Transport Packaging (RTP), listed at Euronext Amsterdam, announced that State Minister for Economic Affairs, Agriculture and Rural Areas, Colette Boos-John, and the District Administrator of Saale-Orla, Christian Herrgott, visited its Cabka GmbH site in Weira, Thuringia yesterday to learn more about the role of the circular economy in sustainable industrial development. During a tour of the production facilities, the delegation gained insights into how hard-to-recycle plastic waste is processed into high-quality recyclates and durable products for the logistics and construction sectors. “Companies like Cabka demonstrate how industrial value creation and resource...

Continue reading

Completion of divestment of aerospace business to SpaceX

(Oslo, Norway, 13 March 2026) Reference is made to the stock exchange release published on 5 February 2026 regarding Hexagon Purus ASA’s (“Hexagon Purus” or the “Company”) agreement to divest its U.S. aerospace business to SpaceX. The transaction has now been completed following satisfaction of the agreed closing conditions. For more information: Mathias Meidell, IR Director, Hexagon Purus ASATelephone: +47 909 82 242 | mathias.meidell@hexagonpurus.com About Hexagon Purus ASA Hexagon Purus enables zero emission mobility for a cleaner energy future. The company is a world leading provider of hydrogen Type 4 high-pressure cylinders and systems, battery systems and vehicle integration solutions for fuel cell electric and battery electric vehicles. Hexagon Purus’ products are used in a variety of applications including light, medium...

Continue reading

IBA Notice of Full Year 2025 Results and Conference Call

FY25 results webcast to take place on Friday, 27 March 2026 at 3pm CET Louvain-la-Neuve, Belgium, 13 March 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today that it will publish its consolidated results for the full year 2025 on Friday, 27 March 2026 at 7am CET. Conference Call Information IBA’s management team will host team will host a conference call and webcast conducted in English to present the half year results, followed by a Q&A session. The conference call will be held on Friday, 27 March 2026 at 3pm CET / 2pm BST / 10am EDT / 7am PDT as a Teams webinar. To attend the webcast, register via this link. The presentation will be available on IBA’s investor relations website and on: https://www.iba-worldwide.com/iba-full-year-2025-results-press-release-conference-call...

Continue reading

Havila Kystruten AS: Trading Update February 2026

Operational Highlights FebruaryOccupancy reached 73%, up from 64% last February, with one less roundtrip this year. Average Cabin Revenue (ACR) increased by about 10% compared to February 2025. Total ticket revenue increased by about 15% compared to February last year. Onboard sales grew by 6% compared to February last year.Booking Position 2026Solid booking trajectory, with 66% of 2026 capacity now booked — around 10 percentage points (or roughly 20%) ahead of the same time last year. We target 10–15% ACR growth across cabin categories for 2026, supporting continued revenue growth and EBITDA margin expansion.Booking Position 202713% of 2027 capacity is booked, about 1% points or 10% ahead of same time last year.*The KPIs provided are sourced from the Company’s (unaudited) booking system. Consequently, there may be variations...

Continue reading

Kyivstar Revenue Rises 26% YoY as Digital and Connectivity Drive Growth

Kyivstar Group Ltd (“Kyivstar,” the “Group”) FY25 and 4Q25 results highlightsTotal revenue for FY25 grew 25.9% to USD 1,157 mn (30.3% to UAH 48.2 bn) year-on-year (“YoY”). 4Q25 revenue increased 28.4% to USD 321 mn (30.1% to UAH 13.5 bn) YoY. EBITDA for FY25 rose 25.8% to USD 648 mn (30.0% to UAH 27.0 bn) with an EBITDA margin of 56.0%. In 4Q25, EBITDA increased 21.7% to USD 172 mn (23.1% YoY to UAH 7.2 bn) with the EBITDA margin at 53.5%. Adjusted net profit was USD 289 mn for FY25, with earnings per share of USD 1.32. Unadjusted net profit was USD 124 mn, EPS USD 0.57, the differences from adjusted numbers resulting from the USD 162 mn non-cash charge related to the Kyivstar listing in 3Q25. Unadjusted net profit for 4Q25 was USD 90 mn. Digital revenue grew 4.7x in FY25 to USD 124 mn (4.9x to UAH 5.2 bn), reaching 10.7% of the revenue...

Continue reading

VEON Delivers Record Digital Growth: 4Q25 Digital Revenues Grow 84% to 20.1% of Total, Driving 17% Revenue and 29% EBITDA Growth in 4Q25

VEON Delivers Record Digital Growth: 4Q25 Digital Revenues Grow 84% to 20.1% of Total, Driving 17% Revenue and 29% EBITDA Growth in 4Q25 Dubai and New York, March 13, 2026 – VEON Ltd. (NASDAQ: VEON), a global digital operator, today announced strong financial and operating results for the fourth quarter and full year ended December 31, 2025. Key Highlights – Fourth Quarter 2025Total revenue grew 17.4% year-on-year (“YoY”) to USD 1,171 million. EBITDA increased 29.1% YoY to USD 527 million, with EBITDA margin expanding 410 bps to 45.0%. Digital revenues grew 84.1% YoY to USD 235 million, accounting for 20.1% of Group revenue. Financial services revenues rose 28.1% YoY to USD 120 million.Key Highlights – Full Year 2025Total revenue increased 9.9% YoY to USD 4,399 million. EBITDA rose 18.8% YoY to USD 2,009 million, with EBITDA margin...

Continue reading

Tree Island Steel Announces Full Year 2025 Results

VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) — Tree Island Steel (“Tree Island” or the “Company”) (TSX: TSL) today reported its financial results for the year ended December 31, 2025. For the three-month period ended December 31, 2025, revenues, net of freight and distribution, were $32.4 million, compared with $44.8 million in the same period last year. The decline primarily reflected lower U.S. sales volumes due to the ongoing impact of expanded U.S. tariffs on wire and wire products, as well as the Company’s strategic withdrawal from certain unprofitable product lines. These factors were partially offset by continued growth in Canadian sales, consistent with the Company’s increased focus on domestic markets. For the full year, revenues totaled $161.8 million, down from $207.0 million in 2024. Despite higher average...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.